These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17097688

  • 1. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF.
    Life Sci; 2007 Jan 09; 80(5):484-92. PubMed ID: 17097688
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ.
    Int J Oncol; 2004 Apr 09; 24(4):853-60. PubMed ID: 15010822
    [Abstract] [Full Text] [Related]

  • 3. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY, Wu WK, Chu KM, Wong HP, Lam EK, Tai EK, Koo MW, Cho CH.
    Mol Cancer Res; 2005 Nov 09; 3(11):607-15. PubMed ID: 16317086
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, Lin JT.
    J Biomed Sci; 2005 Nov 09; 12(1):229-41. PubMed ID: 15864753
    [Abstract] [Full Text] [Related]

  • 5. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH, Li ZR, Zhou X, Ouyang YZ, Zhou ZY, Zeng L.
    Ai Zheng; 2006 Apr 09; 25(4):414-20. PubMed ID: 16613672
    [Abstract] [Full Text] [Related]

  • 6. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
    Goto T, Ishikawa H, Matsumoto K, Nishimura D, Kusaba M, Taura N, Shibata H, Miyaaki H, Ichikawa T, Hamasaki K, Nakao K, Maeshima Y, Eguchi K.
    Int J Oncol; 2008 Jul 09; 33(1):33-40. PubMed ID: 18575748
    [Abstract] [Full Text] [Related]

  • 7. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M.
    Int J Mol Med; 2006 Feb 09; 17(2):245-52. PubMed ID: 16391822
    [Abstract] [Full Text] [Related]

  • 8. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
    Lei T, Han S, Guo XY, Ding R, Li Y, Xie HH, Bai FH, Wu KC, Ding J.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 12; 87(22):1570-5. PubMed ID: 17785115
    [Abstract] [Full Text] [Related]

  • 9. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.
    Chen G, Wang Y, Zhou M, Shi H, Yu Z, Zhu Y, Yu F.
    Oncol Rep; 2010 Feb 12; 23(2):563-70. PubMed ID: 20043122
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of fractalkine inhibits the in vitro and in vivo angiogenesis of the hepatocellular carcinoma HepG2 cells.
    Li F, Wang Z, Liu Y, Li J.
    Oncol Rep; 2010 Sep 12; 24(3):669-75. PubMed ID: 20664972
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 12. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2003 Mar 01; 37(3):696-704. PubMed ID: 12601367
    [Abstract] [Full Text] [Related]

  • 13. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T.
    Biochem Pharmacol; 2008 Aug 01; 76(3):330-9. PubMed ID: 18599020
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines.
    Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G, Ziche M, Mazzanti R.
    Cancer Res; 2006 Mar 01; 66(5):2673-82. PubMed ID: 16510587
    [Abstract] [Full Text] [Related]

  • 15. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P.
    Breast Cancer Res; 2006 Mar 01; 8(6):R69. PubMed ID: 17156488
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
    Churchman A, Baydoun AR, Hoffman R.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):176-83. PubMed ID: 17643408
    [Abstract] [Full Text] [Related]

  • 17. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST.
    Clin Cancer Res; 2006 Dec 01; 12(23):6910-9. PubMed ID: 17145808
    [Abstract] [Full Text] [Related]

  • 18. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
    Hamsa TP, Kuttan G.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):64-73. PubMed ID: 20858484
    [Abstract] [Full Text] [Related]

  • 19. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G, Takata Y, Boros LG, Liu J, Okada Y, Reber HA, Hines OJ.
    Cancer Res; 2005 Feb 01; 65(3):982-90. PubMed ID: 15705899
    [Abstract] [Full Text] [Related]

  • 20. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade.
    Li J, Huang S, Armstrong EA, Fowler JF, Harari PM.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1477-85. PubMed ID: 16029810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.